Insider Monkey1d agoneutral
Some Experts Think TransMedics Group (TMDX) Has a Near-Monopoly on Keeping Donor Organs AliveNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
102last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Schaeffer's Investment Research2d agoneutral
Unusual Options Volume Report: 3 Stocks Moving After EarningsGuruFocus.com2d agoneutral
TransMedics Group Inc (TMDX) (Q3 2026) Earnings Call Highlights: Record $203 Million Revenue ...PR Newswire9d agoneutral
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire17d agoneutral
TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026Simply Wall St.22d agoneutral
TransMedics Group (TMDX) Stock Looks Undervalued On Current EarningsSimply Wall St.37d agoneutral
TransMedics Group (TMDX) Could Be 19% Undervalued If Its Growth Narrative HoldsMotley Fool40d agobullish
TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?Motley Fool40d agobullish
TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?MT Newswires59d agoneutral
TransMedics Names Fernando Araujo as CFO; Maintains 2026 Revenue OutlookMarketBeat82d agoneutral
TransMedics Targets $2B Opportunity With Kidney Push, European Expansion